By FSD Pharma on Friday, 06 March 2020
Category: Vertically Integrated

FSD Pharma rings the bell to open trading day on the Canadian Securities Exchange

viewFSD Pharma

(CSE: HUGE-NASDAQ: HUGE) Executive Co-Chairman and CEO Dr Raza Bokhari joined Steve Darling from Proactive Vancouver to talk about the company ringing the bell to open the trading day on the CSE. 

Dr Bokhari also discussed their phase 1 first-in-human safety and tolerability trials for PP 101 micro-PEA 

CSE:HUGE

Market: CSE
Market Cap: $49.56 m
Follow

View company profile

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of FSD Pharma named herein, including the promotion by the Company of FSD Pharma in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Deep dive

FSD Pharma is building a mammoth hydroponic indoor cannabis production...

Most read

FSD Pharma advancing its Phase 1 study in Australia

FSD Pharma Inc (CSE:HUGE) (NASDAQ:HUGE) CEO Raza Bokhari sat down with Proactive’s Christine Corrado at BIO CEO in New York. Bokhari says the Cobourg, Ontario-based company will initiate Phase 1 safety trials in patients for its lead drug candidate PP 101 micro-PEA in before the end of 1Q,...

3 weeks, 5 days ago

2 min read

Related Posts